Higher levels of response on clinical atopic dermatitis severity measures are associated with meaningful improvements in <scp>patient‐reported</scp> symptom and quality of life measures: Integrated analysis of three Upadacitinib phase 3 trials

Subjects

Subjects :

Infectious Diseases
Dermatology

Details

ISSN :

14683083 and 09269959

Database :

OpenAIRE

Journal :

Journal of the European Academy of Dermatology and Venereology

Accession number :

edsair.doi...........4045d25e12eeff23374f424891a83346

Full Text :

https://doi.org/10.1111/jdv.18995